[HTML][HTML] Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular …
C Shi, K Huang, J Soto, R Sankaran, V Kalia… - Biomedicine & …, 2023 - Elsevier
Ocular retinoblastoma malignancies, which develop into metastatic phenotypes, result in
poor prognosis and survival for infant and child patients. To improve the prognosis of …
poor prognosis and survival for infant and child patients. To improve the prognosis of …
Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles
C Shi, K Huang, J Soto, R Sankaran… - Biomedicine & …, 2023 - pubmed.ncbi.nlm.nih.gov
Ocular retinoblastoma malignancies, which develop into metastatic phenotypes, result in
poor prognosis and survival for infant and child patients. To improve the prognosis of …
poor prognosis and survival for infant and child patients. To improve the prognosis of …
[HTML][HTML] Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular …
C Shi, K Huang, J Soto, R Sankaran… - Biomedicine & …, 2023 - ncbi.nlm.nih.gov
Ocular retinoblastoma malignancies, which develop into metastatic phenotypes, result in
poor prognosis and survival for infant and child patients. To improve the prognosis of …
poor prognosis and survival for infant and child patients. To improve the prognosis of …
Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles.
C Shi, K Huang, J Soto, R Sankaran… - Biomedicine & …, 2023 - europepmc.org
Ocular retinoblastoma malignancies, which develop into metastatic phenotypes, result in
poor prognosis and survival for infant and child patients. To improve the prognosis of …
poor prognosis and survival for infant and child patients. To improve the prognosis of …
Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles.
C Shi, K Huang, J Soto, R Sankaran… - Biomedicine & …, 2023 - europepmc.org
Ocular retinoblastoma malignancies, which develop into metastatic phenotypes, result in
poor prognosis and survival for infant and child patients. To improve the prognosis of …
poor prognosis and survival for infant and child patients. To improve the prognosis of …